GEn1E Lifesciences
gen1e.com
Actively hiring
Artificial Intelligence
Rare Disease Therapeutics
Health Care
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$22.5M
2 rounds on record
Latest round
$5.5M
Venture round · Oct 2025 · 11 mo ago
Team
51-200
employees, estimated range
Backers
2
Y Combinator, StartX
The money's age
Fresh money
11 months since the last round · not hiring
Momentum
20/100
fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Oct 21, 2025
Raised a round Venture round $5.5M · SEC Form D
Oct 24, 2023
Partnership GEn1E Lifesciences Announces Partnership with BARDA to Advance its AI-powered Endotyping Program for ARDS Patients to Further Accelerate its Novel, L… · wtnh.com
Dec 21, 2022
Board appointment Dr. Alan Levy, Director · SEC Form D
Dec 6, 2022
Raised a round Venture round $17M · SEC Form D
Jun 2019
Went through Y Combinator
2018
Founded
Tractionpublic signals, read monthly
Web presence
top 6%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Oct 2025 | $5.5M | — | SEC Form D |
| Venture round | Dec 2022 | $17M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | GEN1E LIFESCIENCES INC. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Ritu LalExecutive Officer, DirectorSEC Form D
Soujanya BhumkarExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Y Combinator Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Celestial Therapeutics is developing novel therapies based on innovative and groundbreaking science to treat, prevent and cure infectious…
NBO (acronym for Nasal Bioavailability of Octreotide) Pharma Inc. was incorporated in 2021 to develop a drug for the treatment of…
Overview. Ambros Therapeutics, headquartered in San Diego, California, is a clinical-stage biotechnology company focused on the development…
Human cells cannot degrade cholesterol, leading to several chronic and orphan diseases. Repair Biotechnologies’ Cholesterol Degrading…
AMO Pharma is dedicated to making a positive difference for people affected by serious and debilitating diseases, particularly rare or…
Mendra is a venture-backed rare-disease biopharma accelerating the development and commercialization of de-risked breakthrough therapies.
News
US FDA Grants Orphan Drug and Rare Pediatric Disease Designations to GEn1E Lifesciences' Dual Signal Modulator for the Treatment of Duchenne Muscular Dystrophy
Read more
Report
GEn1E Lifesciences Publishes Breakthrough Research Unveiling Novel Mechanism of Action of Dual Signal Modulators for Anti-inflammatory and Endothelial-Stabilizing Therapies
Read more
Report
GEn1E Lifesciences Publishes Breakthrough Research Unveiling Novel Mechanism of Action of Dual Signal Modulators for Anti-inflammatory and Endothelial-Stabilizing Therapies
PALO ALTO, Calif., Oct. 14, 2024 (GLOBE NEWSWIRE) -- GEn1E Lifesciences, a clinical-stage Phase 2 company, and a leading innovator in precision therapies for inflammatory and rare diseases, with a strong partnership with the University of Maryland, Baltim
Read more
Report
GEn1E Lifesciences Announces Partnership with BARDA to Advance its AI-powered Endotyping Program for ARDS Patients to Further Accelerate its Novel, Lead Compound GEn-1124
Read more
Report
Dr. Sham Dholakia joins GEn1E Lifesciences as Chief Medical Officer, as it further scales its AI/ML platform, portfolio and partnerships
Read more
Report
Inside the Silicon Valley 'brain trust' taking aim at COVID-19
Start-ups combine forces to find solutions to COVID-19 problems.
Read more
Report
Show more news
People
Ritu Lal
Executive Officer, Director
Soujanya Bhumkar
Executive Officer, Director
Francois Nader
Director
Alan Levy
Director
Noor Kamruddin
Director
Dr. Alan Levy
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
San Francisco
United States
HQ
50-200 est. staff